Filing Flows › Expeditors International of Washington (EXPD) › Stock forecast & fair value
Expeditors International of Washington (EXPD) stock forecast and fair value
Expeditors International of Washington (EXPD) trades at $188.87. 15 analysts' median price target is $197.00 (+4%), from $100.00 to $245.00. Across 27 valuation methods the middle fair value is $146.58 (-22%); the DCF says $186.56.
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| Regime-switching Monte Carlo 10th–90th | $158.92 | $282.87 | $820.61 | +50% |
| DCF — Monte Carlo 10th–90th percentile | $94.66 | $186.56 | $351.97 | -1% |
| P/E vs peers | $110.74 | $133.87 | $227.79 | -29% |
| P/E vs peers, weighted | $125.36 | $191.04 | $295.79 | +1% |
| P/E vs peers, matched | $117.55 | $181.75 | $279.96 | -4% |
| EV/EBITDA vs peers | $100.60 | $131.67 | $189.27 | -30% |
| EV/EBITDA vs peers, weighted | $116.33 | $153.65 | $190.80 | -19% |
| EV/EBITDA vs peers, matched | $102.67 | $131.67 | $169.85 | -30% |
| EV/Sales vs peers | $91.23 | $146.58 | $380.47 | -22% |
| EV/Sales vs peers, weighted | $89.86 | $160.25 | $282.14 | -15% |
Expeditors International of Washington's latest quarter
Expeditors International of Washington, Q3 2026: revenue $4.1B (+42% year over year), operating margin 10.8%, net earnings $345M, operating cash flow $213M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for EXPD stock?
The median of 15 analysts' 12-month targets is $197.00, +4% from $188.87; the range is $100.00 to $245.00. The average rating is hold.
What is Expeditors International of Washington's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $7.48 and $282.87, with a middle value of $146.58 against a price of $188.87. Each method's assumptions are on the page.
Does Expeditors International of Washington usually beat earnings estimates?
It beat the consensus EPS estimate in 100% of the quarters on record.
Is EXPD stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.